Author

L. Klenow

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 3 Organism:mouse· 2

Frequent Co-Authors

H. Wan· 2 shared J. Gao· 2 shared R. Daniels· 2 shared E. M. Coyle· 1 shared G. Grubbs· 1 shared H. Golding· 1 shared H. Kang· 1 shared J. F. Cipollo· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

H. Wan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Modernizing the original influenza vaccine to enhance protective antibody responses against neuraminidase antigens

M. Rakic-Martinez, J. Gao, H. Wan, H. Kang, L. Klenow, R. Daniels

This study enhances influenza vaccine efficacy by improving NA antibody responses through modified virions and recombinant NA proteins in a mouse model.

bioRxiv · Feb 20, 2023 · PreprintMicrobiology

Design of the recombinant influenza neuraminidase antigen is crucial for protective efficacy

J. Gao, L. Klenow, L. M. Parsons, T. Malik, J.-N. Phue, Z. Gao, S. Withers, J. F. Cipollo, R. Daniels, H. Wan

This study evaluates how different designs of recombinant influenza neuraminidase (rNA) affect protective efficacy in mice, showing that domain combinations significantly influence immunogenicity and protection.

bioRxiv · Apr 29, 2021Microbiology

Antibody repertoire induced by SARS-CoV-2 spike protein immunogens

S. Ravichandran, E. M. Coyle, L. Klenow, J. Tang, G. Grubbs, S. Liu, T. Wang, H. Golding, S. Khurana

This study evaluates antibody responses to different SARS-CoV-2 spike protein antigens in rabbits, finding that the RBD antigen elicited higher affinity and titer neutralizing antibodies.

bioRxiv · May 12, 2020Microbiology